KN-25ND-L5

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameKN-25ND-L5
Drug Alias NameKN-25ND-L5
ClassificationBiologics > Mitochondrial Therapeutics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPrimary Ovarian Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHefei Connaught Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHefei Connaught Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPrimary Ovarian Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A